Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NCI-2021-06581 | Registry Identifier | CTRP (Clinical Trial Reporting Program) | |
| STUDY00023019 | Other Identifier | OHSU Knight Cancer Institute | |
| R01CA255016 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Kaiser Permanente | OTHER |
| OCHIN, Inc. | OTHER |
| Oregon Health and Science University | OTHER |
| National Cancer Institute (NCI) |
Not provided
Not provided
Not provided
This phase IV clinical trial determines the impact of implementing a Quitline electronic (e)Referral system with an enhanced academic detailing implementation strategy on Quitline reach, tobacco cessation assistance and self-reported quit rates among patients in community health centers. It also examines the cost-effectiveness of Quitline eReferrals both with and without enhanced academic detailing. If this implementation strategy is effective, this strategy could be used to increase tobacco cessation treatment through the collaboration between state Quitlines and community health centers that serve large numbers of socioeconomically disadvantaged patients who use tobacco.
PRIMARY OBJECTIVES:
I. Implement a Quitline electronic (e)Referral system with enhanced academic detailing (AD) (intervention; n=10 community health centers [CHCs]) and without enhanced AD (comparison; n=10 CHCs) to compare rates of eReferral offers, eReferral acceptance, Quitline enrollment, orders for tobacco cessation medication, and receipt of in-clinic counseling among patients identified as currently using tobacco.
II. Assess the effectiveness of implementing a Quitline eReferral system with enhanced AD (intervention) versus without enhanced AD (comparison) on self-reported tobacco quit rates among all patients identified as current persons using tobacco using electronic health record (EHR) data.
III. Estimate the total annual costs and incremental cost-effectiveness of a Quitline eReferral system, with and without enhanced AD.
OUTLINE: Clinics are randomized to 1 of 2 arms.
ARM I: Clinics are notified via email that the eReferral system is available with a link to an online publication that includes an overview of Quitline services, information on Quitline effectiveness, and a detailed eReferral workflow with corresponding electronic health record (EHR) screenshots, including how to identify eligible patients, create an eReferral, and access Quitline follow-up data in the EHR. Clinics also gain access to technological assistance, as needed.
ARM II: Clinics receive standard online materials and access to remote technological assistance as in Arm I. Clinics also receive group training of clinic staff prior to activation of the Quitline eReferral system and 12 months post-activation, follow-up booster sessions and monthly performance audit and feedback.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Arm I (Quitline eReferral) | Active Comparator | Clinics are notified via email that the Quitline eReferral system is available with a link to an online publication that includes an overview of Quitline services, information on Quitline effectiveness, and a detailed eReferral workflow with corresponding EHR screenshots, including how to identify eligible patients, create an eReferral, and access Quitline follow-up data in the EHR. Clinics also gain access to technological assistance, as needed. |
|
| ARM II (Quitline eReferral plus enhanced AD) | Experimental | Clinics receive standard online materials access to remote technological assistance as in Arm I. Clinics also receive group training of clinic staff prior to activation of the eReferral system and 12 months post-activation, follow-up booster sessions and monthly performance audit and feedback. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Enhanced Academic Detailing | Behavioral |
|
| Measure | Description | Time Frame |
|---|---|---|
| Accepted electronic (e)Referral to Quitline | Proportion of patients who accepted a Quitline eReferral in intervention (EAD) versus comparator clinics. Will use a logistic mixed effects model that addresses the following design features of the study: 1) will include random intercept for clinic to account for clustering of patients within clinics; 2) will perform an intent-to-treat analysis; 3) hypothesis tests will be two-sided. | At any point during the 24-month intervention period |
| Measure | Description | Time Frame |
|---|---|---|
| Quitline eReferral offered | Proportion of patients who were offered the Quitline eReferral in intervention (EAD) versus comparator clinics. Will construct similar logistic mixed effects models. | At any point during the 24-month intervention period |
| Quitline enrollment |
| Measure | Description | Time Frame |
|---|---|---|
| Tobacco use assessed | Proportion of patients who had a current tobacco use assessment in intervention (EAD) versus comparator clinics. | At any point during the 24-month intervention period |
Study Clinic Inclusion Criteria:
Study Patient Inclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Steffani Bailey | OHSU Department of Family Medicine | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| OHSU Knight Cancer Institute | Portland | Oregon | 97239 | United States |
Limited data set was given by partner research organization under data use agreement that excludes disclosure of any data outside of this study.
Not provided
Not provided
Not provided
Not provided
Not provided
| NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Informational Intervention | Other | Receive overview of Quitline services and use of Quitline eReferral via online materials |
|
Proportion of patients who accepted the Quitline eReferral and enrolled in Quitline services in intervention (EAD) versus comparator clinics. Will construct similar logistic mixed effects models. |
| At any point during the 24-month intervention period |
| Receipt of in-office counseling | Proportion of patients with an indication in the electronic health record (EHR) of receipt of counseling during an office visit in intervention (EAD) versus comparator clinics. Will construct similar logistic mixed effects models. | At any point during the 24-month intervention period |
| Tobacco cessation medication ordered | Proportion of patients with a tobacco cessation medication in the 'medication orders' list of the EHR in intervention (EAD) versus comparator clinics. Will construct similar logistic mixed effects models. | At any point during the 24-month intervention period |
| Tobacco cessation | Proportion of patients with EHR status change from current to former tobacco use. Will utilize similar generalized linear mixed model (GLMM) modeling to estimate the impact of the intervention on cessation outcomes. | At any point during the 24-month intervention period or up to 6 months post-intervention |
| Annual intervention costs | Mean total annual costs in years 1-4 to implement the eReferral into the EHR and maintain eReferral system, with and without enhanced academic detailing. | Years 1-4 |
| Cost-effectiveness | Mean total annual costs over years 1-4 by study arm, overall and for patients enrolled in the Quitline. | Years 1-4 |
| Incremental cost-effectiveness ratio | Difference in total costs by study arm, overall and for patients enrolled in Quitline. | Years 1-4 |
| ID | Term |
|---|---|
| D012907 | Smoking |
| D020340 | Tobacco Use Cessation |
| ID | Term |
|---|---|
| D001519 | Behavior |
| D015438 | Health Behavior |
Not provided
Not provided